Every 4 1/2 minutes, a baby is born with a birth defect in United States every year and affects 1 in every 33 babies born in the United States each year. That translates into about 120,000 babies.
Increasing Demand for Personalized Medicine
For instance, according to the American Cancer Society, in 2019, total estimated 1,762,450 new cancer cases were diagnosed and 606,880 cancer deaths in the U.S.
Growing Development of the Healthcare Industry
In 2019, the NIH of the US government invested USD460 million in breast cancer which has increased to USD3.5 billion in the year of 2022.
Recent Development
- In May 2022, BioSkryb Genomics first announced the Early Access Program (EAP) for ResolveOME. With this one-cell process, the whole genome and full-length mRNA transcripts of the whole transcriptome can be amplified from a single cell.
- In January 2022, Parse Biosciences, a company that helps researchers with single-cell sequencing, made a deal with Research Instruments Ptv Ltd to sell Parse's Evercore Whole Transcriptome Kits (WTKs), Cell Fixation Kits, and Nuclei Fixation Kits in Singapore and the rest of Southeast Asia.
- 10x Genomics Chromium Single Cell Gene Expression SolutionThis platform was launched in 2018 and enables the high-throughput analysis of gene expression in individual cells. The platform is widely used in research and drug discovery applications.
- Illumina NovaSeq 6000 SystemThis system was launched in 2017 and is a high-throughput sequencing platform that enables the analysis of transcriptomes, genomes, and epigenomes. The platform is widely used in research and clinical applications.
- NanoString nCounter Analysis SystemThis system was launched in 2019 and enables the multiplexed analysis of gene expression in various sample types, including tissues, blood, and other bodily fluids. The platform is widely used in research, drug discovery, and clinical applications.
- Takara Bio SMARTer Stranded Total RNA-Seq Kit v3This kit was launched in 2020 and enables the high-throughput analysis of stranded RNA-Seq libraries. The kit is widely used in research and drug discovery applications.
- Fluidigm C1 Single-Cell Auto Prep System This system was launched in 2018 and enables the isolation and analysis of individual cells for gene expression analysis. The platform is widely used in research and drug discovery applications.
Market Segmentation
The global transcriptomics market can be segmented by component, by technology, by application, by end user and by region. Based on component, the market can be segmented into Instruments, Consumables, and Software & Services. Based on technology, the market can be differentiated into Next Generation Sequencing, Polymerase Chain Reaction, Microarray, In-Situ Hybridization, and Others. Based on application, the market can be segmented into Drug Discovery & Development, Cell Biology, Single Cell Analysis, Gene Expression, and Others. Based on end user, the market can be segmented into Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global transcriptomics market on account of increasing demand for personalized medicine in the country.
Market Players
Agilent Technologies, Inc., ANGLE plc., Bio-Rad Laboratories, Inc., Becton, Dickinson, and Company, Fluidigm Corporation, BioSypder, Inc., Danaher Corporation (Cytiva), 10x Genomics, Inc., Pacific Biosciences of California, Inc., NanoString Technologies, Inc. are some of the leading players operating in the Global Transcriptomics Market.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · By Component · By Technology · By Application · By End User · By Region |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Egypt; Turkey |
Key companies profiled | Agilent Technologies, Inc., ANGLE plc., Bio-Rad Laboratories, Inc., Becton, Dickinson, and Company, Fluidigm Corporation, BioSypder, Inc., Danaher Corporation (Cytiva), 10x Genomics, Inc., Pacific Biosciences of California, Inc., NanoString Technologies, Inc. |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |